Michelle Ross, StemPoint Capital CIO, joins ‘Closing Bell’ to discuss the small and mid-cap biotech stocks, the patent cliff coming for the companies in the sector and much more.
StemPoint Capital | ‘Closing Bell’
Michelle Ross, Stempoint Capital CIO, joins ‘Closing Bell’ to talk her perspective on the Biotech sector, companies she is watching in the space, and more.
The JCP Platform experienced a second consecutive year of record investment activity across high-quality opportunities.
Click to see a collection of charts pertaining to the digital assets landscape.